Children with SMA1 Show Remarkable Progress on Gene Therapy – MD Magazine
MD Magazine |
Children with SMA1 Show Remarkable Progress on Gene Therapy
MD Magazine Cecilia Pessoa Gingerich. @CeciliaKPG. Researchers testing AVXS-101 gene therapy for the treatment of children with spinal muscular atrophy type 1 reported remarkable progress on the Children’s Hospital of Philadelphia Infant Test of Neuromuscular … |
MD Magazine |
Children with SMA1 Show Remarkable Progress on Gene Therapy
MD Magazine Cecilia Pessoa Gingerich. @CeciliaKPG. Researchers testing AVXS-101 gene therapy for the treatment of children with spinal muscular atrophy type 1 reported remarkable progress on the Children’s Hospital of Philadelphia Infant Test of Neuromuscular … |
|
STEMCELL Technologies announces $45 million government funding for advanced manufacturing facility
Voiceonline.com STEMCELL Technologies, Canada’s largest biotechnology company, on Wednesday announced a $45 million joint funding agreement between the Governments of Canada and British Columbia to help the company build a state-of-the-art advanced manufacturing … |
CBS Pittsburgh / KDKA |
Immunotherapy Offering New Approach To Treating Cancer
CBS Pittsburgh / KDKA “I said, I saw it on television, what about this immunotherapy?” she asked her doctor. Her doctors said it wasn’t approved for her type of cancer, but then everything changed. “When I go to the hospital, he says, ‘I’m going to send your tumor in. The … |
OncLive |
Emerging Immunotherapy Options for Metastatic NSCLC
OncLive I’m not sure we will reach really better data giving only immunotherapy checkpoint inhibitors. But then you have combination of checkpoints plus chemotherapy, and you have the combination of checkpoint and checkpoint, so CTLA-4 and anti-PD-1 or anti-PD … |